论文信息 - Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy

Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy

Methotrexate (MTX) may have adverse effects on multiple organs and system. A few cases of pulmonary tuberculosis in-patients with rheumatoid arthritis (RA) while receiving MTX monotherapy has been reported in the literature. We submit a case of vertebral tuberculosis with hypercalcemia in a patient receiving MTX monotherapy. Patient with RA taking MTX for 15 years developed pancytopenia, skin necrosis, tuberculous spondylodiscitis and hypercalcemia. The present case showed adverse effects of MTX therapy may occur even after years of continuous treatment. Due to pancytopenia in older patients, life-threatening tuberculosis at unusual sites may develop.

[1] E. Bröcker,et al. Methotrexate-induced toxic epidermal necrolysis-like skin toxicity. , 2007, European journal of dermatology : EJD.

[2] Y. Yazici. Methotrexate induced pancytopenia is rare and concern for it should not limit its use. , 2006, Rheumatology.

[3] D. Scott,et al. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. , 2005, Rheumatology.

[4] R. Cooper,et al. Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis. , 2001, Rheumatology.

[5] B. Milleron,et al. Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. , 1988, The American review of respiratory disease.